These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27689338)

  • 21. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.
    Liu Y; Peng H; Zhang JT
    Mol Pharmacol; 2005 Aug; 68(2):430-8. PubMed ID: 15901850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib.
    Gromicho M; Magalhães M; Torres F; Dinis J; Fernandes AR; Rendeiro P; Tavares P; Laires A; Rueff J; Sebastião Rodrigues A
    Oncol Rep; 2013 Feb; 29(2):741-50. PubMed ID: 23229016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
    Reed K; Hembruff SL; Laberge ML; Villeneuve DJ; Côté GB; Parissenti AM
    Epigenetics; 2008 Sep; 3(5):270-80. PubMed ID: 19001875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib.
    Théou N; Gil S; Devocelle A; Julié C; Lavergne-Slove A; Beauchet A; Callard P; Farinotti R; Le Cesne A; Lemoine A; Faivre-Bonhomme L; Emile JF
    Clin Cancer Res; 2005 Nov; 11(21):7593-8. PubMed ID: 16278376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
    Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
    PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
    Kühnle M; Egger M; Müller C; Mahringer A; Bernhardt G; Fricker G; König B; Buschauer A
    J Med Chem; 2009 Feb; 52(4):1190-7. PubMed ID: 19170519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
    Pick A; Wiese M
    ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug resistance mediated by ABC transporters].
    Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone.
    Nieth C; Lage H
    J Chemother; 2005 Apr; 17(2):215-23. PubMed ID: 15920909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
    Heffeter P; Jakupec MA; Körner W; Chiba P; Pirker C; Dornetshuber R; Elbling L; Sutterlüty H; Micksche M; Keppler BK; Berger W
    Biochem Pharmacol; 2007 Jun; 73(12):1873-86. PubMed ID: 17445775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor.
    Teng QX; Lei ZN; Wang JQ; Yang Y; Wu ZX; Acharekar ND; Zhang W; Yoganathan S; Pan Y; Wurpel J; Chen ZS; Fang S
    Drug Resist Updat; 2024 Mar; 73():101028. PubMed ID: 38340425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
    Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance.
    Nimisha ; Saluja SS; Sharma AK; Nekarakanti PK; Apurva ; Kumar A; Sattar RSA; Anjum H; Batra VV; Husain SA
    Mol Cell Biochem; 2023 Oct; 478(10):2379-2394. PubMed ID: 36720839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.
    Balaji SA; Udupa N; Chamallamudi MR; Gupta V; Rangarajan A
    PLoS One; 2016; 11(5):e0155013. PubMed ID: 27171227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.
    Goler-Baron V; Assaraf YG
    PLoS One; 2012; 7(4):e35487. PubMed ID: 22530032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New uracil analog as inhibitor/modulator of ABC transporters or/and NF-κB in taxol-resistant MCF-7/Tx cell line.
    Długosz-Pokorska A; Janecki T; Janecka A; Gach-Janczak K
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):328. PubMed ID: 38914845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCG2 expression, function, and promoter methylation in human multiple myeloma.
    Turner JG; Gump JL; Zhang C; Cook JM; Marchion D; Hazlehurst L; Munster P; Schell MJ; Dalton WS; Sullivan DM
    Blood; 2006 Dec; 108(12):3881-9. PubMed ID: 16917002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
    Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
    Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.